Biogen Idec Ventures

Biogen Ventures is the corporate venture capital arm of Biogen, a global leader in neuroscience and rare diseases. The fund focuses on investing in early-stage biotechnology companies that are developing transformative therapies and platform technologies that align with Biogen's strategic priorities. Its primary areas of interest include neurology, neuropsychiatry, and specialized immunology. In addition to providing financial capital, the group offers portfolio companies access to Biogen's deep expertise in drug development, regulatory affairs, and commercialization. The firm typically engages in Series A and Series B rounds, seeking to foster innovation that addresses significant unmet medical needs. Since its inception, Biogen Ventures has built a diverse portfolio of companies ranging from preclinical startups to clinical-stage entities.